PGIM India Healthcare Fund · Regular · Growth
NAV
₹12.4700
as of 16 Nov 2026
Expense Ratio
2.65%
AUM
₹118 Cr
Lumpsum returns (CAGR)
- 1Y
- +23.71%
- 3Y
- —
- 5Y
- —
- Since Inception
- +12.03%
SIP returns (XIRR)
- 1Y
- +33.80%
- 3Y
- —
- 5Y
- —
- Since Inception
- +22.31%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Risk Metrics
Trailing 1 year, annualised1.03
Sharpe Ratio
+0.15
Alpha
0.58
Beta
1.07
Sortino
12.14%
Std Dev
-10.19%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology64.58%
- Healthcare Services22.75%
- Chemicals & Petrochemicals3.26%
- Insurance2.08%
- Retailing0.89%
- Healthcare Equipment & Supplies0.72%
- IT - Services0.47%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about PGIM India Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Divi'S Laboratories Ltd.11.08%
- 2Sun Pharmaceutical Industries Ltd.10.47%
- 3Torrent Pharmaceuticals Ltd.8.34%
- 4Ajanta Pharma Ltd.5.16%
- 5Dr. Lal Path Labs Ltd.4.34%
- 6Max Healthcare Institute Ltd.4.00%
- 7Mankind Pharma Ltd.3.95%
- 8Navin Fluorine International Ltd.3.26%
- 9Abbott India Ltd.3.22%
- 10Manipal Health Enterprises Ltd.3.18%
What this fund does
PGIM India Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
PGIM India Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by PGIM India Mutual Fund. The fund has been operational for over 1 years. It manages assets worth ₹118 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 2.65%.